BEUDAMED
    FDA Recall Terminated

    Bone Void Filler, sterile orthopedic product, 510 (k) #K053228. The product is delivered in a syringe which is packaged in an aluminum-backed polyethylene pouch and is distributed one (1) pouch per box. The product affected by this recall was distributed by the recalling firm under six (6) different names. They are: Form-Putty; SBvFShape; Valeo BP; X-Putty; TheriGraft Putty; and SynFlow. The product is indicated for use in filling the gaps or voids of osseous defects surgically created or resulting from trauma and are intended for treatment of osseous defects not intrinsic to the stability of the bone structure. The products are intended for use in defects of the skeletal system (i. e. the extremities, spine and pelvis).

    Recall: Z-0169-2011 · Initiated August 26, 2010

    Recall

    Recall Number
    Z-0169-2011
    Event Number
    56858
    Firm
    Theken Spine Llc
    FEI Number
    3002498892
    Product Code
    NOX
    Status
    Terminated
    Root Cause
    Other
    Initiated
    August 26, 2010
    Posted
    November 1, 2010
    Terminated
    October 27, 2011
    Address
    1800 Triplett Blvd, Akron, OH, 44306-3311

    Description

    Bone Void Filler, sterile orthopedic product, 510 (k) #K053228. The product is delivered in a syringe which is packaged in an aluminum-backed polyethylene pouch and is distributed one (1) pouch per box. The product affected by this recall was distributed by the recalling firm under six (6) different names. They are: Form-Putty; SBvFShape; Valeo BP; X-Putty; TheriGraft Putty; and SynFlow. The product is indicated for use in filling the gaps or voids of osseous defects surgically created or resulting from trauma and are intended for treatment of osseous defects not intrinsic to the stability of the bone structure. The products are intended for use in defects of the skeletal system (i. e. the extremities, spine and pelvis).

    Reason

    The firm's quality control testing determined that a separation was occurring between the flowable carrier and the B-TriCalcium Phosphate within some of the product syringes.

    Action

    Theken Spine Llc sent Recall Notification Letters dated August 26, 2010, to all customers. One (1) document, titled an 'Urgent Product Recall Notification' letter was addressed: 'ATTENTION; PRODUCT RECALL COORDINATOR/RISK MANAGER.' The other letter was titled: 'RECALL NOTIFICATION.' The recall letters were accompanied by an attached 'Recall Acknowledgement and Return Form' and were sent out via Federal Express. The letters identified the product, the problem, and the action to be taken by the customer. The letters requested that the customers review their product in inventory and identify any product remaining from the affected lot numbers; part numbers; and/or item names for immediate return of these items to the recalling firm. The letters also asked that the customer complete and return the attached Recall Acknowledgement and Return form according to the instructions provided on the form. In addition, the 'RECALL NOTIFICATION' letter instructed the distributor/customers provide information concerning their sub-account customers to Theken Spine so they could issue a Recall Notification letter to these customers as well. To obtain instructions from the recalling firm concerning product return and issuance of credit, customers were instructed to call (866) 942-8698. For questions regarding this recall call (330) 825-8258.

    Distribution

    Nationwide Distribution - including UT, SD, TX, AL, PA, CA, MI, OH, NJ, NH, MD, ID, FL, LA, NM, TN, IA, and OR.

    Quantity

    2904 units (syringes)